Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
Studying Adrenocortical carcinoma
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- University Medical Center Groningen
- Principal Investigator
- Michiel N Kerstens, MD, PhD, MD PhDUniversity Medical Center Groningen
- Enrollment
- 807 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2023
Study locations (1)
- University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands
Collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam UMC, location VUmc · Radboud University Medical Center · Leiden University Medical Center · Maastricht University Medical Center · UMC Utrecht · Erasmus Medical Center · Martini Hospital Groningen · Canisius-Wilhelmina Hospital · Diakonessenhuis, Utrecht · Isala · Haga Hospital · St. Antonius Hospital · Kennemer Gasthuis · Maxima Medical Center · Medical Center Alkmaar · Frisius Medisch Centrum · Meander Medical Center · Medisch Spectrum Twente · Onze Lieve Vrouwe Gasthuis · Rijnstate Hospital · Elisabeth-TweeSteden Ziekenhuis · Tergooi Hospital · Vlietland Ziekenhuis · Treant ziekenhuis · Flevoziekenhuis
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02324647 on ClinicalTrials.govOther trials for Adrenocortical carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06487481Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaNational Cancer Institute (NCI)
- RECRUITINGPHASE1NCT07189403A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerDaiichi Sankyo
- RECRUITINGPHASE2NCT06587802Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaSun Yat-sen University
- RECRUITINGNCT06279442Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian CohortLatin American Cooperative Oncology Group
- RECRUITINGPHASE2NCT06333314Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIUNICANCER
- RECRUITINGPHASE2NCT06066333Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE2NCT05563467Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.Maria Sklodowska-Curie National Research Institute of Oncology
- RECRUITINGPHASE2NCT05913427Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia